BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7478529)

  • 1. GRB2 and SH-PTP2: potentially important endothelial signaling molecules downstream of the TEK/TIE2 receptor tyrosine kinase.
    Huang L; Turck CW; Rao P; Peters KG
    Oncogene; 1995 Nov; 11(10):2097-103. PubMed ID: 7478529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Tek/Tie2 receptor signals through a novel Dok-related docking protein, Dok-R.
    Jones N; Dumont DJ
    Oncogene; 1998 Sep; 17(9):1097-108. PubMed ID: 9764820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple in vivo phosphorylated tyrosine phosphatase SHP-2 engages binding to Grb2 via tyrosine 584.
    Vogel W; Ullrich A
    Cell Growth Differ; 1996 Dec; 7(12):1589-97. PubMed ID: 8959326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization and down-regulating role of the protein tyrosine phosphatase PTP2C in membrane ruffles of PDGF-stimulated cells.
    Cossette LJ; Hoglinger O; Mou L; Shen SH
    Exp Cell Res; 1996 Mar; 223(2):459-66. PubMed ID: 8601424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of insulin receptor substrate 3 with SH2 domain-containing proteins in rat adipocytes.
    Ross SA; Lienhard GE; Lavan BE
    Biochem Biophys Res Commun; 1998 Jun; 247(2):487-92. PubMed ID: 9642156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Tek/Tie2 binding partners. Binding to a multifunctional docking site mediates cell survival and migration.
    Jones N; Master Z; Jones J; Bouchard D; Gunji Y; Sasaki H; Daly R; Alitalo K; Dumont DJ
    J Biol Chem; 1999 Oct; 274(43):30896-905. PubMed ID: 10521483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of PI 3-kinase and SH-PTP2 in insulin action.
    Kasuga M
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S87-9. PubMed ID: 8894489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific inhibition of FGF-induced MAPK activation by the receptor-like protein tyrosine phosphatase LAR.
    Wang X; Weng LP; Yu Q
    Oncogene; 2000 May; 19(19):2346-53. PubMed ID: 10822386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of tumor necrosis factor-alpha on the phosphorylation of tyrosine kinase receptors is associated with dynamic alterations in specific protein-tyrosine phosphatases.
    Ahmad F; Goldstein BJ
    J Cell Biochem; 1997 Jan; 64(1):117-27. PubMed ID: 9015760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling by Kit protein-tyrosine kinase--the stem cell factor receptor.
    Roskoski R
    Biochem Biophys Res Commun; 2005 Nov; 337(1):1-13. PubMed ID: 16129412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine kinase signalling pathways.
    Pawson T
    Princess Takamatsu Symp; 1994; 24():303-22. PubMed ID: 8983084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors.
    Dumont DJ; Yamaguchi TP; Conlon RA; Rossant J; Breitman ML
    Oncogene; 1992 Aug; 7(8):1471-80. PubMed ID: 1630810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of epidermal growth factor receptor- Grb2-associated binder-1-SHP-2 complex formation and its functional loss during neoplastic cell progression.
    Kameda H; Risinger JI; Han BB; Baek SJ; Barrett JC; Glasgow WC; Eling TE
    Cell Growth Differ; 2001 Jun; 12(6):307-18. PubMed ID: 11432805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of SH-PTP2, a protein-tyrosine phosphatase with Src homology 2 domains, in insulin-stimulated Ras activation.
    Noguchi T; Matozaki T; Horita K; Fujioka Y; Kasuga M
    Mol Cell Biol; 1994 Oct; 14(10):6674-82. PubMed ID: 7935386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2.
    Saxton TM; Henkemeyer M; Gasca S; Shen R; Rossi DJ; Shalaby F; Feng GS; Pawson T
    EMBO J; 1997 May; 16(9):2352-64. PubMed ID: 9171349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antiinflammatory endothelial tyrosine kinase Tie2 interacts with a novel nuclear factor-kappaB inhibitor ABIN-2.
    Hughes DP; Marron MB; Brindle NP
    Circ Res; 2003 Apr; 92(6):630-6. PubMed ID: 12609966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of vascular endothelial growth factor receptor-1 tyrosine phosphorylation sites and binding of SH2 domain-containing molecules.
    Ito N; Wernstedt C; Engström U; Claesson-Welsh L
    J Biol Chem; 1998 Sep; 273(36):23410-8. PubMed ID: 9722576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo.
    Dumont DJ; Gradwohl G; Fong GH; Puri MC; Gertsenstein M; Auerbach A; Breitman ML
    Genes Dev; 1994 Aug; 8(16):1897-909. PubMed ID: 7958865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of protein-tyrosine phosphatase SH-PTP2 by a tyrosine-based activation motif of a novel brain molecule.
    Ohnishi H; Kubota M; Ohtake A; Sato K; Sano Si
    J Biol Chem; 1996 Oct; 271(41):25569-74. PubMed ID: 8810330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SH2-containing protein-tyrosine phosphatase SH-PTP2 is required upstream of MAP kinase for early Xenopus development.
    Tang TL; Freeman RM; O'Reilly AM; Neel BG; Sokol SY
    Cell; 1995 Feb; 80(3):473-83. PubMed ID: 7859288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.